Arthritis Market Research Reports & Industry Analysis
Rheumatoid arthritis (RA) is a systemic inflammatory disease. In the United States, approximately a single percent of the population is affected. Women are two to three times more likely to develop rheumatoid arthritis than men, with peak incidence between the fourth and sixth decades. Gender difference disappears in older age. Rheumatoid arthritis affects all races, and its prevalence is not affected by climate. Eighty percent of rheumatoid arthritis patients test rheumatoid factor (RF) positive.
Arthritis Industry Research & Market Reports
-
Rheumatoid Arthritis Drugs Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis
... that induces pain and inflammation in joints. It influences individuals of all ages; notwithstanding, the geriatric population is highly susceptible to developing this disorder. The symptoms of rheumatoid arthritis embrace pain, stiffness, tenderness, and swelling ... Read More
-
Erosive Hand Osteoarthritis - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Erosive Hand Osteoarthritis Understanding The ... Read More
-
Osteoarthritis - Market Insight, Epidemiology and Market Forecast -2032
... Spain, Italy, France, and United Kingdom) and Japan. The Osteoarthritis market report provides current treatment practices, emerging drugs, Osteoarthritis market share of the individual therapies, current and forecasted Osteoarthritis market Size from 2019 to 2032 ... Read More
-
Non-Radiographic Axial Spondyloarthritis (nrAxSpA) - Market Insight, Epidemiology and Market Forecast -2032
... (nrAxSpA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Non-Radiographic Axial Spondyloarthritis (nrAxSpA) market report provides current treatment practices, emerging drugs, Non-Radiographic Axial Spondyloarthritis (nrAxSpA) market ... Read More
-
Gouty Arthritis (Gout) - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gouty Arthritis (Gout) Understanding The ... Read More
-
Axial Spondyloarthritis (axSpA) - Market Insight, Epidemiology and Market Forecast -2032
... in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Axial Spondyloarthritis (axSpA) market report provides current treatment practices, emerging drugs, Axial Spondyloarthritis (axSpA) market share of the individual therapies, ... Read More
-
Knee Osteoarthritis - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Knee Osteoarthritis market report provides current treatment practices, emerging drugs, Knee Osteoarthritis market share of the individual therapies, current and forecasted Knee Osteoarthritis ... Read More
-
Psoriatic Arthritis - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Psoriatic Arthritis Understanding The DelveInsight Psoriatic Arthritis ... Read More
-
Systemic Juvenile Idiopathic Arthritis (SJIA) - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Systemic ... Read More
-
Juvenile Idiopathic arthritis (JIA) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Juvenile Idiopathic arthritis ... Read More
-
Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Non-Radiographic Axial Spondyloarthritis ... Read More
-
Ankylosing Spondylitis Market by Drug Class (NSAIDs, TNF Inhibitors and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021–2030
... $5,140.94 million in 2020, and is projected to reach $8,110.59 million by 2030, registering a CAGR of 4.6%% from 2021 to 2030. Ankylosing spondylitis (AS) is a rare type of arthritis that causes pain and ... Read More
-
Axial Spondyloarthritis (axSpA) - Epidemiology Insight - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Axial Spondyloarthritis (axSpA) Understanding The ... Read More
-
Polyarticular Juvenile Idiopathic Arthritis - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Polyarticular Juvenile Idiopathic ... Read More
-
Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry
... are characterized by chronic pain, with some of the most common conditions being osteoarthritis (OA) and rheumatoid arthritis (RA), and it is estimated that about one in four adults in America are diagnosed with a ... Read More
Research Assistance
